Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Cancer Research

• Publication date

  2011-11-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-11-0206PMID 22064655PMCID PMC3262123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells

  2011cited by this paper
• Androgen Receptor Survival Signaling Is Blocked by Anti-β2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells*

  2010cited by this paper
• Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression

  2010cited by this paper
• Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration‐resistant prostate cancer in a mouse xenograft model

  2010cited by this paper
• Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase

  2009cited by this paper
• Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma.

  2009cited by this paper
• Oxidative stress in prostate cancer.

  2009cited by this paper
• Saturated fat intake predicts biochemical failure after prostatectomy

  2008cited by this paper
• Cholesterol and Cholesterol-Rich Membranes in Prostate Cancer: An Update

  2008cited by this paper
• Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.

  2008cited by this paper
• The ROS-NOX connection in cancer and angiogenesis.

  2008cited by this paper
• Statins and prostate cancer prevention: where we are now, and future directions

  2008cited by this paper
• Mechanisms of ROS modulated cell survival during carcinogenesis.

  2008cited by this paper
• β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells

  2008cited by this paper
• Phosphoinositide 3-Kinase-independent Non-genomic Signals Transit from the Androgen Receptor to Akt1 in Membrane Raft Microdomains*

  2007cited by this paper
• Purification and Characterization

  2006cited by this paper
• Increased lipogenesis in cancer cells: new players, novel targets

  2006cited by this paper
• β2-Microglobulin Promotes the Growth of Human Renal Cell Carcinoma through the Activation of the Protein Kinase A, Cyclic AMP–Responsive Element-Binding Protein, and Vascular Endothelial Growth Factor Axis

  2006cited by this paper
• Evaluation on the phagocytosis of apoptotic spermatogenic cells by Sertoli cells in vitro through detecting lipid droplet formation by Oil Red O staining.

  2006cited by this paper
• Increased Nox1 and hydrogen peroxide in prostate cancer

  2005cited by this paper
• Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway.

  2005cited by this paper
• Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer.

  2005cited by this paper
• The emerging role of the PI3-K-Akt pathway in prostate cancer progression

  2005cited by this paper
• In support of fatty acid synthase (FAS) as a metabolic oncogene: Extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells

  2005cited by this paper
• Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.

  2004cited by this paper
• Androgen receptor in prostate cancer.

  2004cited by this paper
• Dysregulation of Sterol Response Element-Binding Proteins and Downstream Effectors in Prostate Cancer during Progression to Androgen Independence

  2004influential reference
• Androgens, lipogenesis and prostate cancer.

  2004cited by this paper
• Fatty acid synthase: A metabolic oncogene in prostate cancer?

  2004cited by this paper
• Redox stress regulates cell proliferation and apoptosis of human hepatoma through Akt protein phosphorylation

  2003cited by this paper
• NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells.

  2003cited by this paper
• Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention--a mechanistic approach.

  2003cited by this paper
• Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes.

  2001cited by this paper
• Androgen receptor signaling in androgen-refractory prostate cancer.

  2001cited by this paper
• LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis

  2000influential reference
• Dietary fat and prostate cancer: current status.

  1999cited by this paper
• Calcium‐dependence of hydrogen peroxide‐induced c‐fos expression and growth stimulation of multicellular prostate tumor spheroids

  1997cited by this paper
• The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

  1997cited by this paper
• Two Tandem Binding Sites for Sterol Regulatory Element Binding Proteins Are Required for Sterol Regulation of Fatty-acid Synthase Promoter*

  1996cited by this paper
• Role for sterol regulatory element binding protein in the regulation of farnesyl diphosphate synthase and in the control of cellular levels of cholesterol and triglyceride: evidence from sterol regulation-defective cells.

  1996cited by this paper
• Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide.

  1996cited by this paper
• The androgen receptor in prostate cancer.

  1996influential reference
• Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene.

  1996cited by this paper
• Role of oxygen free radicals in cancer development.

  1996cited by this paper
• Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

  1994cited by this paper
• SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

  1994cited by this paper
• Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization.

  1993cited by this paper
• Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence.

  1993cited by this paper
• [Origin of cancer cells].

  1956cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Cancer cells].

  1950cited by this paper
• Tumorigenesis and Neoplastic Progression Ezetimibe Is an Inhibitor of Tumor Angiogenesis

  year unknowncited by this paper

• Deciphering the role of zinc in prostate health: From mechanism to therapeutic application.

  2026cites this paper
• Therapeutic interference of SREBP-mediated lipid metabolism by E-Xanthohumol attenuates prostate cancer progression.

  2026cites this paper
• Tumor innervation and mitochondrial transfer in the cancer pathogenesis: perspectives on genitourinary malignancies

  2026cites this paper
• Molecular Mediators of Metabolic Reprogramming in Cancer: Mechanisms, Regulatory Networks, and Therapeutic Strategies

  2025cites this paper
• Effects of Docosahexaenoic Acid on Prostate Cancer

  2025cites this paper
• Metabolic reprogramming, malignant transformation and metastasis: lessons from chronic lymphocytic leukaemia and prostate cancer.

  2025cites this paper
• SREBP1a induced PINK1-Parkin mediated mitophagy facilitates ovarian cancer progression.

  2025cites this paper
• Androgen regulates seasonal changes in triglyceride synthesis through the AR-SREBP1-FASN axis in the scented glands of muskrats (Ondatra zibethicus).

  2025cites this paper
• MRPL55 promotes BC progression as a prognostic biomarker by modulating lipogenesis and cyclin-dependent kinase pathways, from multi-omics to drug repurposing

  2025cites this paper
• Metabolic reprogramming and functional crosstalk within the tumor microenvironment (TME) and A Multi-omics anticancer approach

  2025cites this paper
• Mitochondrial lipid metabolism in metastatic breast cancer

  2024cites this paper
• Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer

  2024cites this paper
• Metabolic adaptations in prostate cancer

  2024cites this paper
• Prostate Cancer and the Mevalonate Pathway

  2024cites this paper
• Modulation of energetic and lipid pathways by curcumin as a potential chemopreventive strategy in human prostate cancer cells.

  2024cites this paper
• Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy.

  2024cites this paper
• Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non-small cell lung cancer

  2024cites this paper
• Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.

  2024cites this paper
• The Influence of β-Carotene and Its Liposomal Form on the Expression of EMT Markers and Androgen-Dependent Pathways in Different Prostate Cell Lines

  2024cites this paper
• Fructose, Another Sweet for Cancer: A Context Acting Nutrient Hypothesis

  2023cites this paper
• Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification

  2023cites this paper
• Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer

  2023cites this paper
• Targeting lipid metabolism in metastatic prostate cancer

  2023cites this paper
• The mechanism of long-chain acyl-CoA synthetase 3 in inhibiting cell proliferation, migration, and invasion in clear cell renal cell carcinoma.

  2023cites this paper
• Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting

  2023cites this paper
• Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications

  2023cites this paper
• PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer

  2023cites this paper
• A positive feedback loop between ZEB2 and ACSL4 regulates lipid

  2023cites this paper
• The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery

  2023cites this paper
• Chitosan-Based Sustained Expression of Sterol Regulatory Element-Binding Protein 1a Stimulates Hepatic Glucose Oxidation and Growth in Sparus aurata

  2023cites this paper
• A positive feedback loop between ZEB2 and ACSL4 regulates lipid metabolism to promote breast cancer metastasis

  2023cites this paper
• New insights into lipid metabolism and prostate cancer (Review)

  2023cites this paper
• Elucidation of scandenolone as anti-cancer activity through impairment of the metabolic and signaling vulnerabilities in prostate cancer.

  2023cites this paper
• Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives.

  2023cites this paper
• Key events in cancer: Dysregulation of SREBPs

  2023cites this paper
• Role of Metabolism and Metabolic Pathways in Prostate Cancer

  2023cites this paper
• Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact

  2023cites this paper
• The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer

  2023cites this paper
• Mammalian lipid droplets: structural, pathological, immunological and anti-toxicological roles.

  2023cites this paper
• Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer

  2022influential citation
• Targeting lipid metabolism in the treatment of ovarian cancer

  2022cites this paper
• ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors

  2022cites this paper
• Lipid metabolism in tumor microenvironment: novel therapeutic targets

  2022cites this paper
• Statins and prostate cancer—hype or hope? The biological perspective

  2022cites this paper
• Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer

  2022cites this paper
• SREBP1c-PARP1 axis tunes anti-senescence activity of adipocytes and ameliorates metabolic imbalance in obesity.

  2022cites this paper
• A comprehensive understanding of hnRNP A1 role in cancer: new perspectives on binding with noncoding RNA

  2022cites this paper
• Statin as a therapeutic agent in gastroenterological cancer

  2022cites this paper
• Androgens and low density lipoprotein-cholesterol interplay in modulating prostate cancer cell fate and metabolism.

  2022cites this paper
• Cancer as a Metabolic Disorder

  2022cites this paper
• Alpinumisoflavone Exhibits the Therapeutic Effect on Prostate Cancer Cells by Repressing AR and Co-Targeting FASN- and HMGCR-Mediated Lipid and Cholesterol Biosynthesis

  2022cites this paper
• Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?

  2022cites this paper
• Ferredoxin reductase and p53 are necessary for lipid homeostasis and tumor suppression through the ABCA1–SREBP pathway

  2022cites this paper
• The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer

  2022cites this paper
• Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment

  2022cites this paper
• A novel prognostic model based on cellular senescence-related gene signature for bladder cancer

  2022cites this paper
• Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics

  2022cites this paper
• Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers

  2022cites this paper
• Apoptosis induction in human prostate cancer cells related to the fatty acid metabolism by wogonin-mediated regulation of the AKT-SREBP1-FASN signaling network.

  2022cites this paper
• Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1/FASN-driven metabolism and AR.

  2021cites this paper
• Spatial transcriptomics reveals gene expression characteristics in invasive micropapillary carcinoma of the breast

  2021cites this paper
• Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Fatty acid synthesis and prostate cancer

  2021cites this paper
• E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.

  2021cites this paper
• Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma

  2021cites this paper
• Prostate Cancer Progression: as a Matter of Fats

  2021cites this paper
• ACTIVITY OF H2O2 DEGRADATION ENZYMES IN THE RAT KIDNEYS UNDER THE CONDITIONS OF DIFFERENT NUTRIENT SUPPLY

  2021cites this paper
• Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

  2021cites this paper
• Strength Training Modulates Prostate of Wistar Rats Submitted to High-Fat Diet

  2020cites this paper
• UBC12‐mediated SREBP‐1 neddylation worsens metastatic tumor prognosis

  2020cites this paper
• Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancer.

  2020cites this paper
• Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

  2020cites this paper
• Implications of lipid droplets in lung cancer: Associations with drug resistance

  2020cites this paper
• Emerging Therapeutic Activity of Davallia formosana on Prostate Cancer Cells through Coordinated Blockade of Lipogenesis and Androgen Receptor Expression

  2020influential citation
• Role of the Sterol Regulatory Element Binding Protein Pathway in Tumorigenesis

  2020cites this paper
• NOX2-Derived Reactive Oxygen Species in Cancer

  2020cites this paper
• Metabolic Plasticity in Chemotherapy Resistance

  2020cites this paper
• Strength training protects against prostate injury in alcoholic rats

  2020cites this paper
• Lipid droplets: platforms with multiple functions in cancer hallmarks

  2020cites this paper
• NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27

  2020cites this paper
• OTT_A_266073 8951..8961

  2020cites this paper
• Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women

  2020cites this paper
• Revisiting prostate cancer metabolism: From metabolites to disease and therapy

  2020cites this paper
• Inhibiting the Activity of NADPH Oxidase in Cancer

  2020cites this paper
• Alterations in Metabolite-Driven Gene Regulation in Cancer Metabolism

  2020cites this paper
• Non-Coding and Regulatory RNAs as Epigenetic Remodelers of Fatty Acid Homeostasis in Cancer

  2020cites this paper
• Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells

  2020cites this paper
• SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer

  2020cites this paper
• Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells

  2020cites this paper
• Cancer Cell Metabolism: A Potential Target for Cancer Therapy

  2020cites this paper
• Cholesterol and beyond - The role of the mevalonate pathway in cancer biology.

  2020cites this paper
• The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy

  2020cites this paper
• Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer

  2020cites this paper
• Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsies

  2019cites this paper
• Interplay of PKD3 with SREBP1 Promotes Cell Growth via Upregulating Lipogenesis in Prostate Cancer Cells

  2019cites this paper
• Aberrant Protein Phosphorylation in Cancer by Using Raman Biomarkers

  2019cites this paper
• Essential role of O-GlcNAcylation in stabilization of oncogenic factors.

  2019cites this paper
• Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer.

  2019cites this paper
• Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update

  2019cites this paper
• Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer

  2019cites this paper